Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report

By afschroeder • October 24, 2025

Le X, Baik C, Cho BC, Riess JW, Piotrowska Z, Johannes de Langen A, Goldberg SB, Goldman JW, Reguart N, Shiraishi Y, Ambrose H, Fraenkel PG, Ruiz BM, Smith PE, Tang KH, Yu HA. Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report. J Thorac Oncol. 2025 Oct 21:S1556-0864(25)02856-4. doi: 10.1016/j.jtho.2025.10.009. Epub ahead of print. PMID: 41130408.

Tags: Cardiology/Epi, EGFR, MET (min 3), NSCLC, Osimertinib, Publications, Savolitinib (max 5)

Diet patterns are associated with progression of coronary artery calcification and differ across race/ethnicity: The Multi-Ethnic Study of Atherosclerosis

Momin M, Baylin A, Garner J, Watson K, Inoue K, Brandt EJ. Diet patterns are associated with progression of coronary artery calcification and differ across[...]

Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores – Part I: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis and Framingham Heart Study

Naghavi M, Azimi A, Atlas K, Reeves AP, Zhang C, Mirjalili SR, Mozafarybazargany M, Jolfayi AG, Hashemi A, Atlas T, Wasserthal J, Vliegenthart R, Henschke[...]

A Knowledge Graph Framework for Longitudinal Congenital Heart Disease Modeling: Methodology Corner

Xu H, Cunge L, Ming Z, Chen S, Husain M, Renella P, Lluri G, Finn JP, Hsu W, Nguyen KL. A Knowledge Graph Framework for[...]